ASX: INF · Five-year financial review

(ASX: INF) Infinity Metals Limited Financial Review - FY2021~25

Infinity Metals’ five-year record moves from a capital-funded FY2021 through recurring operating and investing outflows, a PERTE-grant-expanded FY2024 balance sheet, and a sharply smaller FY2025 Group position after the San José impairment and grant return.

Years ended 30 June 2021-2025 · A$ million unless stated · Group financial statements and issuer explanations from the frozen annual-extraction packet. · Editorial review: 2026-10-03 · MII Research

Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.

FY2021 cash
A$19.135m

Closing cash after the capital-funded year.

FY2024 grant-linked liabilities
A$31.593m

Includes A$30.228m deferred income.

FY2025 cash
A$5.130m

Issuer-reported consolidated cash.

FY2025 impairment
A$20.284m

San José carrying-value reduction.

Five years in context

FY2021 was capital-funded for San José feasibility, licence and environmental work. Its reported profit was materially shaped by a A$4.888m impairment reversal of an equity-accounted investment, while share-based payments were a A$1.420m expense; it should not be read as recurring operating profitability.

Over FY2022-FY2023, recurring operating and investing outflows accompanied continued San José expenditure. The issuer attributed the FY2023 working-capital reduction to that project activity, not to a revenue transition.

The FY2024 expanded balance sheet incorporated PERTE grant-related security, restricted deposits and deferred income. Those arrangements make the headline financial position different from ordinary unrestricted operating liquidity.

Events behind the numbers

FY2021

Placement-funded San José work

A$15.1m before costs was raised for feasibility, licence and environmental applications.

FY2023

Permit progression amid cash use

An exploration permit covering the San José resource area was granted while cash funded project expenditure.

FY2024

Grant-related balance-sheet expansion

PERTE security and restricted deposits mean the enlarged asset base was not unrestricted operating liquidity.

FY2025

Grant withdrawal, impairment and Highland acquisition

The issuer withdrew from PERTE VEC IIa, impaired San José, and acquired Highland’s eastern Victorian licences through a cash-and-equity asset acquisition.

FINANCIAL REVIEW / 01

Group liquidity and financial position

Cash moved from A$19.135m to A$5.130m. The FY2024 increase coincided with PERTE balances. FY2025 reported net assets of A$3.001m and liabilities of A$2.978m; tabled assets of A$5.978m is transparently calculated from those reported amounts.

The packet does not select FY2025 cash-flow subtotals. It does identify returned PERTE funds as driving working-capital decline and separately records the San José impairment.

Closing cash

A$ million

Closing cashCash and cash equivalents: FY2021 19.135; FY2022 16.288; FY2023 12.306; FY2024 13.118; FY2025 5.13005.3610.7216.0721.43FY2021FY2022FY2023FY2024FY2025Cash and cash equivalents, FY2021: 19.135 A$ million19.135Cash and cash equivalents, FY2022: 16.288 A$ million16.288Cash and cash equivalents, FY2023: 12.306 A$ million12.306Cash and cash equivalents, FY2024: 13.118 A$ million13.118Cash and cash equivalents, FY2025: 5.130 A$ million5.130
Cash and cash equivalents
A$ million. Each cell uses its source-report scale.

AI-generated presentation · values from Consolidated financial position; no missing values plotted as zero.

Net assets and liabilities

A$ million

Net assets and liabilitiesNet assets: FY2021 27.220; FY2022 25.282; FY2023 27.482; FY2024 24.545; FY2025 3.001 | Total liabilities: FY2021 1.210; FY2022 1.307; FY2023 0.499; FY2024 31.593; FY2025 2.97808.8517.6926.5435.38FY2021FY2022FY2023FY2024FY2025Net assets, FY2021: 27.220 A$ millionNet assets, FY2022: 25.282 A$ millionNet assets, FY2023: 27.482 A$ millionNet assets, FY2024: 24.545 A$ millionNet assets, FY2025: 3.001 A$ millionTotal liabilities, FY2021: 1.210 A$ millionTotal liabilities, FY2022: 1.307 A$ millionTotal liabilities, FY2023: 0.499 A$ millionTotal liabilities, FY2024: 31.593 A$ millionTotal liabilities, FY2025: 2.978 A$ million
Net assetsTotal liabilities
A$ million. Grant and impairment effects limit comparability.

AI-generated presentation · values from Consolidated financial position; no missing values plotted as zero.

Consolidated financial position

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Cash and cash equivalents19.13516.28812.30613.1185.130
Total assets (FY2025 calculated: net assets + liabilities)28.43126.58927.98156.1385.978
Total liabilities1.2101.3070.49931.5932.978
Net assets27.22025.28227.48224.5453.001

A$ million. FY2025 cash and net assets are issuer-reported consolidated narrative figures; its total assets is a labelled editorial calculation, not a separately reported line.

FY2024 includes PERTE grant-related balances; FY2025 reflects grant return and San José impairment.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

FINANCIAL REVIEW / 02

Cash deployment and funding

Operating cash flow was negative in every selected FY2021-FY2024 year. Investing was negative through FY2023 before a positive FY2024 subtotal, which is not operating performance.

Financing supplied A$20.236m in FY2021, A$0.964m in FY2022 and A$3.341m in FY2023; FY2024 is explicitly nil.

Operating, investing and financing cash flows

A$ million

Operating, investing and financing cash flowsNet cash from/(used in) operating activities: FY2021 (0.940); FY2022 (2.554); FY2023 (3.091); FY2024 (2.399) | Net cash from/(used in) investing activities: FY2021 (0.789); FY2022 (1.255); FY2023 (4.218); FY2024 3.223 | Net cash from financing activities: FY2021 20.236; FY2022 0.964; FY2023 3.341; FY2024 0.000-5.691.538.7415.9623.17FY2021FY2022FY2023FY2024Net cash from/(used in) operating activities, FY2021: (0.940) A$ millionNet cash from/(used in) operating activities, FY2022: (2.554) A$ millionNet cash from/(used in) operating activities, FY2023: (3.091) A$ millionNet cash from/(used in) operating activities, FY2024: (2.399) A$ millionNet cash from/(used in) investing activities, FY2021: (0.789) A$ millionNet cash from/(used in) investing activities, FY2022: (1.255) A$ millionNet cash from/(used in) investing activities, FY2023: (4.218) A$ millionNet cash from/(used in) investing activities, FY2024: 3.223 A$ millionNet cash from financing activities, FY2021: 20.236 A$ millionNet cash from financing activities, FY2022: 0.964 A$ millionNet cash from financing activities, FY2023: 3.341 A$ millionNet cash from financing activities, FY2024: 0.000 A$ million
Net cash from/(used in) operating activitiesNet cash from/(used in) investing activitiesNet cash from financing activities
A$ million. FY2024 financing is explicitly nil; FY2025 is outside this selected-lane table.

AI-generated presentation · values from Cash-flow lanes through FY2024; no missing values plotted as zero.

Cash-flow lanes through FY2024

A$ million

MetricFY2021FY2022FY2023FY2024
Net cash from/(used in) operating activities(0.940)(2.554)(3.091)(2.399)
Net cash from/(used in) investing activities(0.789)(1.255)(4.218)3.223
Net cash from financing activities20.2360.9643.3410.000

A$ million; statutory consolidated cash-flow subtotals. The FY2024 investing inflow is not operating revenue.

No equivalent FY2025 three-lane subtotal is selected in the frozen packet.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

FINANCIAL REVIEW / 03

Result profile and accounting-basis change

FY2021’s A$2.457m profit includes a A$4.888m impairment reversal of the equity-accounted investment, partially offset by A$1.420m share-based payments. It is an accounting-driven result, not evidence of recurring operating profit.

In October 2022, following €600,000 deferred consideration, the Group assumed control of TEL in an asset acquisition. Its interest remained 75% with a 25% non-controlling interest intact; the separate tables preserve the resulting shift from equity-accounted investment to consolidated deferred exploration accounting.

FY2025’s A$23.889m statutory loss was primarily associated with a A$20.284m San José impairment. The accounting reduction is not described as FY2025 cash expenditure.

The deferred exploration balance fell from A$17.731m to A$0.277m. The issuer identified permitting delays, depressed lithium pricing and market-capitalisation-to-net-assets disparity as impairment indicators; this is its disclosed basis, not an independent valuation.

Reported annual profit/(loss)

A$ million

Reported annual profit/(loss)Profit/(loss) for the year: FY2021 2.457; FY2022 (6.322); FY2023 (3.914); FY2024 (3.675); FY2025 (23.889)-25.47-17.7-9.93-2.155.62FY2021FY2022FY2023FY2024FY2025Profit/(loss) for the year, FY2021: 2.457 A$ million2.457Profit/(loss) for the year, FY2022: (6.322) A$ million(6.322)Profit/(loss) for the year, FY2023: (3.914) A$ million(3.914)Profit/(loss) for the year, FY2024: (3.675) A$ million(3.675)Profit/(loss) for the year, FY2025: (23.889) A$ million(23.889)
Profit/(loss) for the year
A$ million. FY2021 is a profit; later values are losses.

AI-generated presentation · values from Reported result and project carrying balance; no missing values plotted as zero.

Exploration additions, impairment and closing balance

A$ million

Exploration additions, impairment and closing balanceDeferred exploration and evaluation additions: FY2024 2.928; FY2025 0.504 | Deferred exploration impairment: FY2024 0.000; FY2025 (20.284) | Deferred exploration closing balance: FY2024 17.731; FY2025 0.277-22.57-11.35-0.1411.0822.29FY2024FY2025Deferred exploration and evaluation additions, FY2024: 2.928 A$ millionDeferred exploration and evaluation additions, FY2025: 0.504 A$ millionDeferred exploration impairment, FY2024: 0.000 A$ millionDeferred exploration impairment, FY2025: (20.284) A$ millionDeferred exploration closing balance, FY2024: 17.731 A$ millionDeferred exploration closing balance, FY2025: 0.277 A$ million
Deferred exploration and evaluation additionsDeferred exploration impairmentDeferred exploration closing balance
A$ million. Closing balance is shown as accounting context.

AI-generated presentation · values from San José carrying-value reset; no missing values plotted as zero.

Reported result and project carrying balance

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Profit/(loss) for the year2.457(6.322)(3.914)(3.675)(23.889)
Corporate and compliance expenses(0.627)(1.040)(1.226)(1.366)(0.829)

A$ million. FY2021 is a profit; FY2022-FY2025 are losses. Expenses retain reported negative signs.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

TEL equity-accounted investment before control

A$ million

MetricFY2021FY2022
Equity-accounted investment9.1479.817

A$ million. Closing investment balance, not annual project expenditure. This is retained separately because the Group moved to control TEL in October 2022.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

Deferred exploration and evaluation after control

A$ million

MetricFY2023FY2024FY2025
Deferred exploration and evaluation carrying balance14.48917.7300.277

A$ million. Closing carrying balance, not annual cash expenditure. The Group had assumed control of TEL before this series begins.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

San José carrying-value reset

A$ million

MetricFY2024FY2025
Deferred exploration and evaluation additions2.9280.504
Deferred exploration impairment0.000(20.284)
Deferred exploration closing balance17.7310.277

A$ million. Additions and impairment are annual movements; closing balance is a year-end stock.

FY2024 comparative impairment is explicitly nil in the FY2025 note.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

FINANCIAL REVIEW / 04

Project and funding events

San José permit and ECA milestones demonstrate administrative progression, not production, revenue or a development decision.

Highland was acquired as an asset acquisition with A$50,000 cash, shares and performance rights; it is not operating revenue.

Reading the figures

  • FY2021/FY2025 dollar cells and FY2022-FY2024 $’000 cells are individually scaled; no blanket multiplier is used.
  • FY2025 has Group position, loss and exploration facts but no selected three-lane cash-flow subtotal in this packet; this is a packet boundary, not an issuer non-disclosure finding.
  • FY2025 total assets is calculated as reported net assets plus reported liabilities and labelled calculated.
  • The ~€19.8m PERTE return is a May 2025 withdrawal event; the €1.049598m interest was paid in early July 2025 and is not labelled FY2025 cash flow.
  • Prepared from existing year-by-year extraction records only. No raw-source retrieval, database query, financial web research or MiniMax call. GPT review against saved extractions; not an independent original-document audit.

Annual-report source registry

  • Infinity Metals Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
  • Infinity Metals Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
  • Infinity Metals Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
  • Infinity Metals Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
  • Infinity Metals Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.

Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.

Sources, copyright and independence

The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.

Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.

AI-led method

This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.

Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.

Information notice

This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.

It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.

Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.

Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.